RABBIT MUSCLE AND URETHRAL IN SITU BIOCOMPATIBILITY PROPERTIES OF THE SELF-REINFORCED L-LACTIDE-GLYCOLIC ACID COPOLYMER 80: 20 SPIRAL STENT
Authors:
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (3) , 1527-1531
Abstract
A new type of self-reinforced L-lactide-glycolic acid copolymer, molar ratio 80:20, stent was developed. We evaluated the tissue biocompatibility properties of the new material. Rods made of self-reinforced L-lactide-glycolic acid copolymer were inserted into rabbit dorsal muscles and rods of latex or polyvinylchloride and silicone served as positive and negative controls, respectively. Urethral stents of self-reinforced L-lactide-glycolic acid copolymer and steel were inserted in situ via cystoscopy into the rabbit prostatic urethra. The animals were sacrificed after 2 weeks, 1, 2 and 3 months, respectively. In situ histological analysis was done. Tissue reactions around the implantation types were analyzed histologically and scored semiquantitatively. In addition, macroscopic analysis was done of the urethral in situ stents. In rabbit muscle implantation test tissue reaction to the self-reinforced L-lactide-glycolic acid copolymer stent resembled that of negative control silicone. Less than moderate chronic inflammatory changes gradually subsided after 2 weeks. Foreign materials in the tissue and the reaction to these materials began to disappear after 1 month and at 3 months were completely absent. All rabbits fitted with the stent voided normally postoperatively. Self-reinforced L-lactide-glycolic acid copolymer stents were soft, partially fragmented and easily disintegrated when touched at 2 months, and were almost completely degraded at 3 months. The material did not encroach into the urethral wall macroscopically or microscopically. No calcification on the self-reinforced L-lactide-glycolic acid copolymer stents or bladder stone formation was seen. The new self-reinforced L-lactide-glycolic acid copolymer 80:20 material is safe, highly biocompatible and suited for future clinical use. It is most appropriate for preventing postoperative urinary retention after most minimally invasive thermal treatments for benign prostatic hyperplasia.Keywords
This publication has 31 references indexed in Scilit:
- Biomaterials Used in Urology: Current Issues of Biocompatibility, Infection, and Encrustation*Journal of Endourology, 1998
- Bioabsorbable and Biodegradable Stents in UrologyJournal of Endourology, 1997
- A Randomized Study to Compare Biodegradable Self-reinforced Polyglycolic Acid Spiral Stents to Suprapubic and Indwelling Catheters After Visual Laser Ablation of the ProstateJournal of Urology, 1997
- Long-Term Results of Urolume Urethral Stent for Recurrent Urethral StricturesJournal of Urology, 1996
- Biodegradable Self-Reinforced Polyglycolic Acid Spiral Stent in Prevention of Postoperative Urinary Retention After Visual Laser Ablation of the Prostate-Laser ProstatectomyJournal of Urology, 1995
- Biocompatibility of Various Indwelling Double-J StentsJournal of Urology, 1995
- Urethral stents: current status for the treatment of recurrent bulbar urethral strictures and benign prostatic hyperplasiaCurrent Opinion in Urology, 1994
- A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative riskThe Prostate, 1994
- Biodegradable Bone Repair MaterialsClinical Orthopaedics and Related Research, 1986
- In vivo validation of a cell culture test for biocompatibility testing of urinary cathetersJournal of Biomedical Materials Research, 1984